RxDoctor Payments Data

Roberta Hunter, MD

Gastroenterology · Charleston, WVNPI 1093827420

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 52.1% of the total. Reporting peaked in 2024 at $362 and has fallen 76.8% since, to $84 in 2025. That places this record below the midpoint for gastroenterology clinicians in WV, where the typical reported total is $1,371.

$769in general payments, 2019–2025

Across 24 payments — averaging $32.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$401
  • E.r. Squibb & Sons, L.L.C.$101
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$76
  • Pfizer$68
  • Phathom Pharmaceuticals, Inc.$41
  • Boston Scientific$27
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$73896%
  • Education$304%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$769 in reported general payments places this provider in the 30th percentile of 72 gastroenterology providers in West Virginia.

See all gastroenterology providers in West Virginia

Medicare billing

Part B allowed, 2024
$46,327
Medicare patients
243
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium34$176
Lactulose15$139
Famotidine14$104
Carvedilol17$96

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →